首页 >
法规速递
-
Document: Timetable: Type II variation and worksharing application alternative monthly assessment-2025/10/14
2025-10-15查看详情 > -
Document: Scientific advice and protocol assistance adopted during the CHMP meeting 10-13 November 2025-2025/11/18
2025-11-19查看详情 > -
Page: Clinical investigation of medicinal products in the treatment of patients with acute respiratory distress syndrome - Scientific guideline-2025/12/12
2025-12-15查看详情 > -
Page: Avian influenza (bird flu)-2026/1/27
2026-01-28查看详情 > -
M14 General Principles on Planning, Designing, Analyzing, and Reporting of Non-interventional Studies That Utilize Real-World Data for Safety Assessment of Medicines-2026/3/3
2026-03-05查看详情 > -
国家药监局关于40批次不符合规定化妆品的通告（2026年第9号）-2026/4/2
2026-04-03查看详情 > -
国家药监局综合司公开征求《药品上市许可持有人落实药品质量主体责任监督管理规定（征求意见稿）》意见-2022/11/29
2022-11-30查看详情 > -
Regulatory and procedural guideline: Scientific advice under Art.107(6) of Reg.(EU)2019/6 for establishment of a list of antimicrobials which shall not be used in accordance with Art. 112, 113 and 114 or which shall only be used in accordance with these a
2023-06-21查看详情 > -
Page: Calculation of dose factor to be submitted to the Union Product Database (UPD) - Scientific guideline-2023/12/15
2023-12-21查看详情 > -
Document: List of eligible industry stakeholder organisations-2025/1/23
2025-01-23查看详情 >
